Frankfurt
15.05.25 | 08:19
0,069 Euro
+4,89 % +0,003
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,099 | 0,107 | 18:55 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SPINEGUARD Aktie jetzt für 0€ handeln | |||||
| 29.04. | Presentation at CFA Congress of Positive Results Obtained for SpineGuard's New Ultrasound Technology | 280 | Business Wire | Feasibility of entry point and trajectory determination in vertebral drilling
Ideal complement of DSG real-time X Ray-free guidance technology
Collaboration with the LIB and ISIR... ► Artikel lesen | |
| 15.04. | SpineGuard Announces Full-Year 2024 Financial Results and First Quarter 2025 Sales | 251 | Business Wire | Significant reduction in losses of €1.1 million, with consolidated net income improving by 26% in 2024
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys... ► Artikel lesen | |
| 09.04. | SpineGuard and Omnia Medical Announce the Signature of a Binding Term Sheet for the Transfer of SpineGuard Inc. | 249 | Business Wire | Taking a new strategic step forward in the implementation of the common roadmap established by the two companies announced on January 6, 2025 Integration of PediGuard systems into Omnia... ► Artikel lesen | |
| 14.03. | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025 | 802 | Xetra Newsboard | Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen | |
| 10.02. | SpineGuard Announces the Commercial Launch of its "PsiFGuard" New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion | 317 | Business Wire | Innovation developed in partnership with the US company Omnia Medical Omnia launched PsiFGuard at the NANS convention in Orlando, from Jan. 30th to Feb. 1st, 2025
Regulatory News:
SpineGuard... ► Artikel lesen | |
| 10.01. | SpineGuard Reports Its Full-Year 2024 Revenue | 578 | Business Wire | +8% growth globally, +20% in the US
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing technology... ► Artikel lesen | |
| 07.01. | SpineGuard Completes a Bond Financing to Support the Deployment of Its New Products | 943 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 06.01. | SpineGuard and Omnia Medical Announce the Extension of Their Strategic Partnership | 449 | Business Wire | Scope of initial agreement extended to other products and countries Reallocation of personnel and resources to bolster the launch of Omnia products in the United States including PsiFGuard
Regulatory... ► Artikel lesen | |
| 03.01. | SpineGuard announces its 2025 financial calendar | 456 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 09.10.24 | SpineGuard Announces Its Q3 2024 Revenue | 500 | Business Wire | Growth acceleration to continue in Q3 2024: +20% globally and +30% in the US Revenue up +13% over the first 9 months, to €3.6 million
Regulatory News:
SpineGuard (FR0011464452 ALSGD)... ► Artikel lesen | |
| 30.09.24 | SpineGuard Obtains FDA Clearance for Commercial Release of Its "PsiFGuard" New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion | 470 | Business Wire | Innovation developed in partnership with the US company Omnia Medical Key milestone for the deployment of the DSG technology in the United States
Regulatory News:
SpineGuard (FR0011464452... ► Artikel lesen | |
| 11.09.24 | SpineGuard Reports its H1 2024 Financial Results | 404 | Business Wire | Revenue growth by 10% at constant exchange rate Net loss reduced by 20% and EBITDA improved by 30%
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys... ► Artikel lesen | |
| 03.09.24 | SpineGuard obtains EC-MDR certification and launches its Threaded PediGuard for anterior spine surgery in Europe | 524 | Business Wire | Regulatory News:
SpineGuard (Paris:ALSGD)(FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline... ► Artikel lesen | |
| 17.07.24 | SpineGuard Files Its "510K" Dossier in the US for the Clearance of Its New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion | 646 | Business Wire | Innovation developed in partnership with the US company Omnia Medical Acceleration of commercial deployment of SpineGuard in the United States
Regulatory News:
SpineGuard (FR0011464452... ► Artikel lesen | |
| 15.07.24 | SpineGuard Announces its H1 2024 Revenue | 325 | Business Wire | Growth acceleration in Q2, +14% globally (+26% in the US) 10% growth at constant exchange rate in the first half
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company... ► Artikel lesen | |
| 26.06.24 | SpineGuard Reports on Its Annual Shareholders' Meeting of June 26, 2024 | 397 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 20.06.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 20.06.2024 | 625 | Xetra Newsboard | Das Instrument LPHG LU1834988351 LIF-600 PER.+H. EOA ETF wird cum Kapitalmassnahme gehandelt am 20.06.2024 und ex Kapitalmassnahme am 21.06.2024 The instrument LPHG LU1834988351 LIF-600 PER.+H. EOA... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 42,520 | +1,80 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 45 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Nach dem starken Jahresstart der Aktie hätten... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 48,850 | +1,45 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 60 auf 56 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Richard Felton passte... ► Artikel lesen | |
| TELADOC HEALTH | 6,440 | -2,08 % | Teladoc Health, Inc. (TDOC): Among the Best Growth Stocks Under $10 to Buy Right Now | ||
| THERMO FISHER | 360,80 | -0,73 % | Cybin taps Thermo Fisher for potential commercial manufacturing of CYB003 | ||
| EUROFINS SCIENTIFIC | 55,82 | +2,57 % | Eurofins Scientific SE: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| SYNLAB | 12,880 | 0,00 % | Synlab Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
| DAVITA | 124,95 | -0,24 % | DaVita Inc. Reveals Retreat In Q1 Profit | WASHINGTON (dpa-AFX) - DaVita Inc. (DVA) reported a profit for first quarter that decreased from the same period last yearThe company's bottom line totaled $162.92 million, or $2.00 per share.... ► Artikel lesen | |
| SPINEWAY | 0,120 | 0,00 % | Spineway: First-quarter 2025 revenue of €2.8 million | Press release Ecully, April 16, 2025 - 7.00 p.m. SPINEWAY First-quarter 2025 revenue of €2.8 million In thousands of euros20252024Change as a %Q1 revenue2,8283,070-8% Unaudited consolidated... ► Artikel lesen | |
| DENTSPLY SIRONA | 14,555 | -1,22 % | Dentsply Sirona Inc Q1 Profit Increases, Beats Estimates | YORK (PENNSYLVANIA) (dpa-AFX) - Dentsply Sirona Inc (XRAY) reported earnings for its first quarter that increased from last year and beat the Street estimates.The company's earnings came in... ► Artikel lesen | |
| SMITH & NEPHEW | 12,755 | +0,83 % | Smith & Nephew UK Ltd: A comparative sNPWT study of 10,000+ C-sections shows PICO sNPWT reduces complications and cuts healthcare costs by $728,000 per 1,000 patients | Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published comparative study of single-use Negative Pressure Wound Therapy (sNPWT) devices... ► Artikel lesen | |
| SONIC HEALTHCARE | 15,052 | -0,15 % | Sonic Healthcare shares are down more than 40% since 2021. Will its AI initiative be the catalyst for a turnaround? | ||
| ONTRAK | 1,695 | -2,59 % | Ontrak verzeichnet signifikante Verluste im letzten Quartal | ||
| DIASORIN | 93,92 | -0,82 % | Milan: Downbeat day for DiaSorin | ||
| PATTERSON COMPANIES | 27,400 | 0,00 % | Patterson Companies Completes Acquisition by Patient Square Capital | Robert Rajalingam Appointed Chief Executive Officer and to Board of Directors
ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies ("Patterson" or the "Company"), a leading supplier of products... ► Artikel lesen | |
| FULGENT GENETICS | 17,500 | -0,57 % | Fulgent genetics targets $310M core revenue in 2025 with strong growth in diagnostics and pathology |
Das Unternehmen SPINEGUARD SA kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,069 Euro und damit +4,89 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SPINEGUARD SA finden Sie auf Wallstreet Online.